Genscript Biotech Stock Price on September 18, 2023

GNNSF Stock  USD 1.25  0.01  0.79%   
If you're considering investing in Genscript Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Genscript Biotech stands at 1.25, as last reported on the 16th of December 2024, with the highest price reaching 1.25 and the lowest price hitting 1.25 during the day. Genscript Biotech holds Efficiency (Sharpe) Ratio of -0.0797, which attests that the entity had a -0.0797% return per unit of risk over the last 3 months. Genscript Biotech exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genscript Biotech's Market Risk Adjusted Performance of (0.64), risk adjusted performance of (0.05), and Standard Deviation of 2.03 to validate the risk estimate we provide.
  
Genscript Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0797

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsGNNSF

Estimated Market Risk

 2.05
  actual daily
18
82% of assets are more volatile

Expected Return

 -0.16
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Genscript Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genscript Biotech by adding Genscript Biotech to a well-diversified portfolio.

Related Headline

Lineage Cell Headline on 18th of September 2023

Global Autologous Cell Therapy Product Market Size Worth 40.77 Billion By 2030 Latest Research Report Benzinga

Genscript Biotech Valuation on September 18, 2023

It is possible to determine the worth of Genscript Biotech on a given historical date. On September 18, 2023 Genscript was worth 2.42 at the beginning of the trading date compared to the closed value of 2.42. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genscript Biotech pink sheet. Still, in general, we apply an absolute valuation method to find Genscript Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genscript Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genscript Biotech's related companies.
 Open High Low Close Volume
  2.42    2.42    2.42    2.42    1.00  
09/18/2023
  2.42    2.42    2.42    2.42    1.00  
  2.42    2.42    2.42    2.42    1.00  
Backtest Genscript Biotech  |  Genscript Biotech History  |  Genscript Biotech Valuation   PreviousNext  
Open Value
2.42
2.42
Closing Value
8.57
Upside

Genscript Biotech Trading Date Momentum on September 18, 2023

On September 19 2023 Genscript Biotech was traded for  2.42  at the closing time. The highest daily price throughout the period was 2.42  and the lowest price was  2.42 . There was no trading activity during the period 1.0. Lack of trading volume on 09/19/2023 did not cause price change. The overall trading delta to current closing price is 9.09% .

Genscript Biotech Fundamentals Correlations and Trends

By evaluating Genscript Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genscript Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genscript financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Genscript Biotech Pink Sheet history

Genscript Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genscript is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genscript Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genscript Biotech stock prices may prove useful in developing a viable investing in Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the Peoples Republic of China, Japan, the other Asia Pacific regions, and internationally. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the Peoples Republic of China. Genscript Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5573 people.

Genscript Biotech Pink Sheet Technical Analysis

Genscript Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Genscript Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genscript Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Genscript Biotech Period Price Range

Low
December 16, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Genscript Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Genscript Biotech December 16, 2024 Market Strength

Market strength indicators help investors to evaluate how Genscript Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genscript Biotech shares will generate the highest return on investment. By undertsting and applying Genscript Biotech pink sheet market strength indicators, traders can identify Genscript Biotech entry and exit signals to maximize returns

Genscript Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Genscript Biotech's price direction in advance. Along with the technical and fundamental analysis of Genscript Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genscript to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Genscript Pink Sheet analysis

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments